JWH 018 (Item No. 10900) is a synthetic cannabinoid (CB) frequently found in herbal blends that potently activates the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors (Kis = 9.0 and 2.94 nM, respectively). AB-FUBINACA is an indazole-based synthetic CB with 10-fold greater affinity for the CB1 receptor (Ki = 0.9 nM) than that of JWH 018.{22006,22072} AB-FUBINACA was first synthesized by Pfizer as a potent CB1 receptor modulator for potential therapeutic use, but recently was identified along with AB-PINACA (Item No. 14038) in illegal herbal products.{22006,22072} This product is intended for research and forensic applications.
产品描述
An indazole-based synthetic CB with potent affinity for the CB1 receptor (Ki = 0.9 nM); intended for research and forensic applications
